Session Type
Meeting
Search Results for Liver disease
Abstract Number: A8
SHM Converge 2022
Background: Non-Alcoholic Fatty Liver Disease (NAFLD) is defined as the presence of ≥5% of hepatic steatosis (HS) in the absence of other liver disorders, such as chronic viral or autoimmune hepatitis, steatosis induced by drugs, significant alcohol consumption, hemochromatosis, or Wilson’s disease. There is limited literature describing national prevalence and epidemiological characteristics of NAFLD in [...]
Abstract Number: 462
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Wilson Disease (WD) is a known cause of liver test abnormalities. Guidelines have been established to help clinicians avoid routine testing. According to the American Association for the Study of Liver Diseases (AASLD) Guideline, screening for WD—with serum ceruloplasmin, 24-hour urinary copper excretion, and slit-lamp examination for Kayser-Fleischer rings—is warranted in any patient with [...]
Abstract Number: 584
Hospital Medicine 2020, Virtual Competition
Case Presentation: A 47- year-old man with a history of hypothyroidism presented to the emergency room (ER) for the evaluation of generalized body weakness and jaundice of a week duration. There was also associated intense generalized pruritus of about 6 months; subjective weight loss, recurrent fevers, nausea and vomiting. Physical examination was significant for an [...]
Abstract Number: 620
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Case Presentation: 53 year old male with a history of alcohol abuse presented to the ED with hyponatremia and elevated LFTs after a week of nausea, vomiting, and diarrhea. The patient had a previous drinking history of a 12-pack of beer per day, denied IV drug use and any recent travel outside of Texas. Determined [...]
Abstract Number: 0137
SHM Converge 2025
Background: Metabolic dysfunction-associated steatotic liver disease (MALSD) is a recent classification that better reflects the cardiometabolic factors contributing to the condition, while reducing stigma associated with previous terminology. Characterized by triglyceride accumulation, MALSD can progress to inflammation and fibrosis if untreated. Although the FIB-4 score is commonly used to assess liver fibrosis, its association with [...]
Abstract Number: 0513
SHM Converge 2025
Case Presentation: The patient is a 69-year-old female with hemoglobin S/C disease, hypertension, and chronic kidney disease who presented to the hospital for lower back pain in the setting of a fall. CT scan demonstrated an L1 compression fracture and an incidental finding of cystic lesions in the liver and kidneys. Subsequent MRI demonstrated innumerable [...]
Abstract Number: 0552
SHM Converge 2025
Case Presentation: Introduction:Tuberculosis (TB) remains a global health issue, with extrapulmonary TB often mimicking other conditions.¹ Diagnosing tuberculous peritonitis is particularly challenging in resource-limited settings, where nonspecific symptoms and limited diagnostics create barriers. This case highlights the complexities of diagnosing tuberculous peritonitis in a chronic alcoholic patient, initially suspected of decompensated liver disease (DCLD) despite [...]